SEC Form DFiling only, no announcement found
Person Health, based in New York, NY, reported $249,000 sold in a private offering of Simple Agreements for Future Equity (SAFEs), with the first sale on July 28, 2026, in a Form D filed with the SEC on August 25, 2026. The filing says 1 investor has already invested. The offering authorizes up to $5,000,000.
Legal name on the filing: Person Health Inc..
| Amount sold | $249,000Basis: Form D total amount sold, as of the filing of August 25, 2026. Not the announced round size. |
|---|---|
| Total offering | $5,000,000The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $4,751,000 |
| Securities offered | Other (Simple Agreements for Future Equity (SAFEs)) |
| Exemption claimed | Rule 506(b) |
| Date of first sale | July 28, 2026 |
| Investors already invested | 1 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Other Health Care |
| Principal place of business | New York, NY |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | 2026 |
| Revenue range | Decline to Disclose |
| SEC CIK | 2151165 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Yung-Ping Yeh | Executive Officer, Director, PromoterDirector and Chief Executive Officer | None linked |
| Thomas Sheehan | Executive Officer, Director, PromoterChairman and Chief Architect Officer | None linked |
| Ali Khammanivong | Executive Officer, DirectorDirector and Head of R&D, Molecular Diagnostics Platform | None linked |
| Parmjit Kang | Executive OfficerChief Financial Officer | None linked |
| Randy Schiestl | Executive OfficerChief Operating Officer | None linked |
| Greg Sherwood | Executive OfficerHead of R&D, Volatile Diagnostics Platform | None linked |
| Michael Weaver | Executive OfficerChief Growth Officer | None linked |
| Jennifer Schaumburg | Executive OfficerChief Compliance Officer | None linked |
| Murdoc Khaleghi | Executive OfficerChief Medical Officer | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Aug 25, 2026 | D (original) | $249,000 | $5,000,000 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Person Health: SEC Form D deal record", https://vcbeast.com/deals/person-health-form-d-2026-07-28. Source: SEC EDGAR, accession 0002151165-26-000002.